GT Biopharma, Inc.

GTBP·NasdaqCM
Compare
6.80+0.12 (+1.80%)today
At close: Oct 12, 4:00 PM EDT · May be delayed up to 15 min · USD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close6.68
Open6.79
Day range6.527.05
52-week range4.9128.75
Off day high−3.55%
Off 52-week high−76.35%
Volume37.33K
Avg. volume (3M)55.53K
Market cap12.27M
EPS (TTM)-147.50
Forward P/E-0.63
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)—
Shares outstanding1.80M
Short interest—
Earnings dateAug 12, 2025 (est.)
Analyst target—
Profit margin—

Against its peers

Compare in full ›
GTBP GRI INAB TVGN AIM GDTC
Market cap 12.27M 3.43M — 43.49M 7.08M 9.68M
P/E (TTM) — — — — — —
Forward P/E -0.6 -0.8 — — -0.5 -5.4
Price/book 3.4 0.3 — -1.5 0.7 2.5
Dividend yield — — — — — —
1-year change −63.79% −96.64% — −81.03% −93.00% −53.89%
Today +1.80% −9.77% — −1.50% −1.44% −8.83%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Latest news

All GTBP news ›

No recent coverage in the 4Search index.

From articles in the 4Search news index.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Conservative index. Terms of use.